Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade

OBJECTIVE: Destructive thyroiditis is the most common endocrine immune-related adverse event (iRAEs) in patients treated with anti-PD1/PD-L1 agents. Given its self-limited course, current guidelines recommend no treatment for this iRAE. Nevertheless, in patients with enlarged thyroid volume and a po...

Descripción completa

Detalles Bibliográficos
Autores principales: Brancatella, Alessandro, Pierotti, Laura, Viola, Nicola, Lupi, Isabella, Montanelli, Lucia, Cremolini, Chiara, Piaggi, Paolo, Chella, Antonio, Antonuzzo, Andrea, Sgrò, Daniele, Antonangeli, Lucia, Sardella, Chiara, Brogioni, Sandra, Marcocci, Claudio, Santini, Ferruccio, Latrofa, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254312/
https://www.ncbi.nlm.nih.gov/pubmed/35622442
http://dx.doi.org/10.1530/ETJ-22-0030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254312/
https://www.ncbi.nlm.nih.gov/pubmed/35622442
http://dx.doi.org/10.1530/ETJ-22-0030

Ejemplares similares